158 related articles for article (PubMed ID: 32763784)
1. Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis.
Bergamini A; Sarwar N; Ferrandina G; Scarfone G; Short D; Aguiar X; Camnasio C; Kaur B; Savage PM; Cormio G; Lim A; Pignata S; Mangili G; Seckl MJ
Eur J Cancer; 2020 Sep; 137():136-143. PubMed ID: 32763784
[TBL] [Abstract][Full Text] [Related]
2. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases.
Li S; Zhang X; Zhang T; Yin M; Cao D; Xiang Y; Yang J
Ann Med; 2023; 55(2):2273984. PubMed ID: 37909181
[TBL] [Abstract][Full Text] [Related]
4. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
[TBL] [Abstract][Full Text] [Related]
5. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).
Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D
Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258
[TBL] [Abstract][Full Text] [Related]
6. Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study.
Mangili G; Giorda G; Ferrandina G; Cormio G; Cassani C; Savarese A; Danese S; Carnelli M; Vasta FM; Perrone AM; Scarfone G; Pignata S; Legge F; Raspagliesi F; Taccagni G; Candiani M; Bogani G; Mascilini F; Bergamini A
Int J Gynecol Cancer; 2021 Sep; 31(9):1242-1247. PubMed ID: 34035080
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic comparison of active surveillance and adjuvant chemotherapy in the treatment of patients with stage Ⅰ ovarian immature teratoma after fertility-sparing surgery].
Zhang XY; Yang J; Xiang Y; Wu M; Pan LY; Yang JX
Zhonghua Fu Chan Ke Za Zhi; 2023 Nov; 58(11):838-845. PubMed ID: 37981770
[No Abstract] [Full Text] [Related]
8. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative.
Pashankar F; Hale JP; Dang H; Krailo M; Brady WE; Rodriguez-Galindo C; Nicholson JC; Murray MJ; Bilmire DF; Stoneham S; Arul GS; Olson TA; Stark D; Shaikh F; Amatruda JF; Covens A; Gershenson DM; Frazier AL
Cancer; 2016 Jan; 122(2):230-7. PubMed ID: 26485622
[TBL] [Abstract][Full Text] [Related]
9. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD
Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392
[TBL] [Abstract][Full Text] [Related]
10. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.
Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM
Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136
[TBL] [Abstract][Full Text] [Related]
11. Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy.
Marino G; Grassi T; De Ponti E; Negri S; Testa F; Giuliani D; Delle Marchette M; Dell'Oro C; Fumagalli D; Donatiello G; Besana G; Marchetta L; Bonazzi CM; Lissoni AA; Landoni F; Fruscio R
Front Oncol; 2024; 14():1330481. PubMed ID: 38371620
[TBL] [Abstract][Full Text] [Related]
12. Pure pediatric ovarian immature teratomas: The French experience.
Pavone R; Dijoud F; Galmiche L; Ro V; Hameury F; Sarnacki S; Orbach D; Briandet C; Pasquet M; Bertrand A; Fresneau B; Faure-Conter C
Pediatr Blood Cancer; 2020 Apr; 67(4):e28186. PubMed ID: 31981415
[TBL] [Abstract][Full Text] [Related]
13. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
[TBL] [Abstract][Full Text] [Related]
14. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
[TBL] [Abstract][Full Text] [Related]
15. Re: 'Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis'.
Lockley M; Stoneham S; Shamash J; Pashankar F; Frazier L
Eur J Cancer; 2021 Jul; 152():255-256. PubMed ID: 34099362
[No Abstract] [Full Text] [Related]
16. Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis.
Bergamini A; Sarwar N; Ferrandina G; Scarfone G; Short D; Aguiar X; Camnasio C; Kaur B; Savage PM; Cormio G; Lim A; Pignata S; Mangili G; Seckl MJ
Eur J Cancer; 2021 Jul; 152():257-258. PubMed ID: 34112565
[No Abstract] [Full Text] [Related]
17. Pediatric ovarian immature teratoma: Histological grading and clinical characteristics.
Shinkai T; Masumoto K; Chiba F; Shirane K; Tanaka Y; Aiyoshi T; Sasaki T; Ono K; Gotoh C; Urita Y; Takayasu H; Suzuki R; Sakashita S
J Pediatr Surg; 2020 Apr; 55(4):707-710. PubMed ID: 31130350
[TBL] [Abstract][Full Text] [Related]
18. Ovarian immature teratoma: treatment and outcome in a single institutional cohort.
Vicus D; Beiner ME; Clarke B; Klachook S; Le LW; Laframboise S; Mackay H
Gynecol Oncol; 2011 Oct; 123(1):50-3. PubMed ID: 21764111
[TBL] [Abstract][Full Text] [Related]
19. Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients.
Bonazzi C; Peccatori F; Colombo N; Lucchini V; Cantù MG; Mangioni C
Obstet Gynecol; 1994 Oct; 84(4):598-604. PubMed ID: 7522313
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy for early stage endometrioid ovarian carcinoma: An analysis of the National Cancer Data Base.
Nasioudis D; Latif NA; Simpkins F; Cory L; Giuntoli RL; Haggerty AF; Morgan MA; Ko EM
Gynecol Oncol; 2020 Feb; 156(2):315-319. PubMed ID: 31839340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
